Search Results

Pharm Country

DiamiR Biosciences Announces Poster Presentation at 2024 Alzheimer’s Association International Conference (AAIC)

DiamiR, a developer of innovative blood-based diagnostic tests for brain health and other diseases, today announced that it will present a poster at the Alzheimer’s Association International Conference (AAIC), taking place July 28th – Aug 1st, 2024, in Philadelphia, PA, and online.

June 19, 2024

·

2 min read

Pharm Country

DiamiR Announces Oral Presentation on Recent Advances of Its microRNA Biomarker Platform at 2024 International Rett Syndrome Foundation Scientific Meeting

DiamiR Biosciences announced that the company’s co-founder Dr. Kira Sheinerman will present at the 2024 International Rett Syndrome Foundation Rett Syndrome Scientific Meeting, taking place June 18-19, 2024, in Westminster, CO.

June 12, 2024

·

1 min read

Press Releases

DiamiR Biosciences Secures EU Patent Covering the Use of microRNA Biomarkers from Bodily Fluids for Differential Diagnosis of Amyotrophic Lateral Sclerosis

August 1, 2024

·

2 min read

Pharm Country

DiamiR Biosciences Announces Poster Presentation at 52nd Annual Meeting of Child Neurology Society

DiamiR today announced that it will present a poster at the 52nd Child Neurology Society Annual Meeting, taking place October 4-7, 2023, in Vancouver, BC, Canada.

October 2, 2023

·

1 min read

Business

DiamiR Biosciences Partners with JADBio to Utilize Machine Learning in Assay Development

DiamiR Biosciences today announced that it has entered into an agreement with JADBio to utilize its Automated Machine Learning (AutoML) Platform and Services for development of predictive models based on DiamiR’s microRNA panels and other factors for risk assessment in Alzheimer’s disease and Rett syndrome.

July 5, 2023

·

2 min read

Pharm Country

DiamiR Biosciences Announces Publication of Analytical Validation Data for its microRNA Testing Platform

DiamiR Biosciences today announced that the data related to analytical validation of the company’s 24 microRNA panel for risk assessment of Alzheimer’s disease, CogniMIR.

June 28, 2023

·

2 min read

Pharm Country

DiamiR Biosciences Announces Two Poster Presentations at 2023 Alzheimer’s Association International Conference

DiamiR Biosciences today announced that it will present two posters at the Alzheimer’s Association International Conference (AAIC), taking place July 16 – 20, 2023, in Amsterdam, Netherlands.

June 20, 2023

·

1 min read

Pharm Country

DiamiR Biosciences Announces Participation in Alzheimer’s Panel at the BioFuture 2022 Conference

DiamiR, a developer of innovative blood-based diagnostic tests for brain health and other diseases, announced that the company’s management will participate in the BioFuture Conference being held on November 7-9, 2022 at the Lotte New York Palace in New York City, NY.

November 7, 2022

·

1 min read

Pharm Country

DiamiR Biosciences Announces Poster Presentation at the Clinical Trials on Alzheimer’s Disease 2022 Annual Meeting

DiamiR, a developer of innovative blood-based diagnostic tests for brain health and other diseases, today announced that it will present a poster at the 15th Clinical Trials on Alzheimer’s Disease (CTAD), taking place November 29 – December 2, 2022, at the Hilton Union Square in San Francisco, CA, and online.

November 28, 2022

·

1 min read

Business

DiamiR Biosciences Expands Management Team with the Appointment of Fred Knechtel as its Chief Financial Officer

DiamiR today announced the expansion of its management team by the appointment of Fred Knechtel as Chief Financial Officer (CFO), effective immediately.

August 30, 2022

·

2 min read